West Pharmaceutical Services Comprehensive Income 2010-2024 | WST

West Pharmaceutical Services comprehensive income for the quarter ending September 30, 2024 was $-0.136B, a 38.88% decline year-over-year.

  • West Pharmaceutical Services comprehensive income for 2023 was $-0.144B, a 21.42% decline from 2022.
  • West Pharmaceutical Services comprehensive income for 2022 was $-0.183B, a 14.66% increase from 2021.
  • West Pharmaceutical Services comprehensive income for 2021 was $-0.16B, a 44.3% increase from 2020.

West Pharmaceutical Services Comprehensive Income 2010-2024 | WST

  • West Pharmaceutical Services comprehensive income for 2023 was $-0.144B, a 21.42% decline from 2022.
  • West Pharmaceutical Services comprehensive income for 2022 was $-0.183B, a 14.66% increase from 2021.
  • West Pharmaceutical Services comprehensive income for 2021 was $-0.16B, a 44.3% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$79.5B
Becton Dickinson (BDX)$67B
Cardinal Health (CAH)$29.2B
Cooper (COO)$20.7B
Labcorp (LH)$20.3B
Align Technology (ALGN)$16.5B
Henry Schein (HSIC)$8.5B
Merit Medical Systems (MMSI)$6B
DENTSPLY SIRONA (XRAY)$3.6B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.5B
Lifevantage (LFVN)$171M
Pro-Dex (PDEX)$139M